"I announce that starting today, Ruikang Medical's research project inducing hematopoietic stem cell technology will be officially launched!"

"All the biological researchers present will be divided into three groups in the next days, trying to extract c-genes and inject them into hematopoietic stem cells for division and culture, and using transcription factors to induce stem cells to induce differentiation into red blood cells and blood cells!"

"Three groups conduct parallel research, unified management, and cross-swap scientific research results, striving to achieve the application of induced hematopoietic stem cell technology in the laboratory stage in the shortest time!"

Chen Changan announced the final project research direction with a firm conclusion. He is everyone's boss, and his intention is the standard of Ruikang Medical R&D Center.

Although Wang Jia and Fu Tian are still doubtful about the success prospects of this project, they still accepted Chen Changan's decision.

Since he was determined to conduct technical research on artificial blood, the others had to follow him to invest in this research. After all, everyone's salary was paid by Chen Chang'an.

Fortunately, there are many precedents in the international field of induction of hematopoietic stem cell technology in the simple laboratory stage. Whether it is some scientific research teams in Japan or scientific research teams in Europe, they have many successful experiences.

As early as 2007, the Japanese scientific research team used mice hematopoietic stem cells to differentiate 2ml of red blood cells, and then successfully used human hematopoietic stem cells to artificially differentiate a little bit of experimental red blood cells in 17 years.

In 2019, mice were even tested for clinical trials. This artificial blood was used on 10 experimental mice in heavy bleeding. In the end, 6 experimental mice were rescued, which produced the same effect as their own blood in their bodies, and did not cause any side effects such as blood clotting.

Although the country started later than Japan and Europe and the United States, it did not have any results. Moreover, Chen Changan will participate in the entire process of this research and development.

With his snail force joining, there will basically be no technical barriers. The technical details are all contained in his mind. With the help of so many researchers, he has the ability to completely restore the key technology to induce hematopoietic stem cells!

But for the next period of time, I'm afraid he will be very busy, and all three project teams need him to stare at.

"Several mechanics researchers will wait first. After we thoroughly study the theoretical technology, we will work together to develop hematopoietic equipment. I also have some ideas in this regard. I will share with you one after another, so you can do pre-research and development first."

After Chen Changan gave a quick order, he clearly arranged the researchers and then carried out formal scientific research work.

.....

In the scientific research circle, it is really difficult to have any secrets to maintain. Unless it is a national confidentiality project, every research center or institution must report to the relevant departments and be approved for research qualifications before it can conduct corresponding research.

If it is not reported, even if it is illegally studied, it will be banned and will be involved in the bureau...

This is also a hard and unacceptable rule.

After all, if you don’t report it, what should I do if a fool suddenly appears one day and asks a few people to close the door and study biochemical viruses or cloning technologies?

Regardless of whether the research can be successful or not, when they conduct experiments, if some biochemical products or some viral genes have leaked, wouldn’t the entire city have to bear the risk of being cold...

Therefore, no matter the size of the experiment, whether it is safe or not, as long as it is conducting scientific research activities, it must be reported to the relevant departments.

This kind of reporting is basically not a secret, nor does it have any confidentiality measures, and it can be easily learned by peers or those who are interested.

As soon as Chen Changan reported the scientific research projects and experimental requirements, large domestic and foreign medical groups such as Medtronic and Mindray received the news...

The information age is so fast!

In just two days, all medical companies in the circle basically knew about it. Ruikang wanted to enter the deep pit of inducing hematopoietic stem cell technology.

To be honest, Gu Yan from Medtronic actually secretly breathed a sigh of relief when he received this news.

Although he never cared about Ruikang Medical, he felt that Ruikang broke through a blockade and would not have a second time.

But if competition can be avoided, it is naturally the result he is most happy to see.

The technology of inducing hematopoietic stem cells to artificially make blood can be said to basically have scientific research teams in various countries around the world conducting research on this aspect.

There are not many Doruikon Medical's family, and there are not many less him.

This technology is not easily commercialized. Even the scientific research teams under the three giants of GPS are currently at a loss. The fastest-progress research team at the Japanese National Defense Medical University has not yet completed the laboratory research stage.

So when Gu Yan heard that Ruikang Medical was preparing to dive into this deep pit, he was naturally so happy.

This bottomless pit seems to have a bright future, but actually requires huge funds and may not ensure smooth research. Gu Yanba can do more to Ruikang Medical!

As long as Ruikang does not study some medical equipment that have already developed very maturely and compete with Medtronic for food, but instead invests in research on other theoretical technologies or cutting-edge technologies in the near future, Gu Yan naturally doesn't care.

Indeed, he admitted that Ruikang has two brushes to create high-end invasive ventilators, and his scientific research level is still good, which has posed some threats to Medtronic.

However, invasive ventilators, even the highest-end styles, in the overall medical equipment industry, are basically a mid-range and upper-middle device, which has basically matured its technology in the 1990s and has developed to its peak.

In fact, with China's current scientific research level, if a team is willing to devote five or six years to devote themselves to research and development, it can still be done.

However, most companies are not willing to invest large amounts of money and take countless risks in an industry that has been completely monopolized by foreign companies.

This is possible, but it is not necessary.

In other words, Ruikang Medical, a brave and fearless company, suddenly jumped out of the market for some reason, without saying a word, took out mature equipment, and joined forces with domestic ventilator companies to bite a market.

But this time, Ruikang Medical, who is not afraid of death, has focused on the hematopoietic stem cell technology that countless scientific researchers in mankind have not yet successfully made breakthroughs.

Isn’t it a joke to try to clinically and commercially implement artificial blood?

Gu Yan doesn't believe that Ruikang Medical's scientific research team is even more awesome than the top cutting-edge scientific research teams in Japan that have specialized in inducing hematopoietic stem cell technology for more than 20 years.

I have been studying this area for more than 20 years, but the progress is still only at the laboratory stage. If you come up and recruit dozens of scientific researchers, you are hoping to win the crown of biomedicine in the 21st century?
Chapter completed!